Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica was recognized for having the Best Organizational Due Diligence Solution by Private Equity Wire in their 2024 European Awards. The award was based on…
Read moreWealth & Finance International Magazine has announced the winners of this year’s Management Consulting Awards. For the second year running, the Management Consulting Awards looks…
Read moreHumatica advises Freshstream on their investment on Project Better Energy, one of the leading players in the domestic renewable energy sector in the UK Humatica, the…
Read more